<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Prenetics Global Ltd — News on 6ix</title>
<link>https://6ix.com/company/prenetics-global-ltd</link>
<description>Latest news and press releases for Prenetics Global Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/prenetics-global-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b02b78dffbe2df10f905.webp</url>
<title>Prenetics Global Ltd</title>
<link>https://6ix.com/company/prenetics-global-ltd</link>
</image>
<item>
<title>Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-im8-health-partners-with-vitamin-angels-to-combat-global-malnutrition-commits-to-impacting-400000-mothers-and-children-in-year-one</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-im8-health-partners-with-vitamin-angels-to-combat-global-malnutrition-commits-to-impacting-400000-mothers-and-children-in-year-one</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most Vulnerable Populations Long-Term Goal to Impact</description>
</item>
<item>
<title>Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-nba-champion-and-two-time-mvp-giannis-antetokounmpo-as-im8-global-partner-and-shareholder-in-multi-year-partnership-11</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-nba-champion-and-two-time-mvp-giannis-antetokounmpo-as-im8-global-partner-and-shareholder-in-multi-year-partnership-11</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the fastest supplement company ever to reach $100M</description>
</item>
<item>
<title>Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-im8-partners-with-superpower-to-personalize-the-future-of-supplementation</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-im8-partners-with-superpower-to-personalize-the-future-of-supplementation</guid>
<pubDate>Tue, 24 Mar 2026 15:00:00 GMT</pubDate>
<description>IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protoc</description>
</item>
<item>
<title>Prenetics to Participate in the 38th Annual ROTH Conference</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-to-participate-in-the-38th-annual-roth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-to-participate-in-the-38th-annual-roth-conference</guid>
<pubDate>Wed, 18 Mar 2026 12:30:00 GMT</pubDate>
<description>NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA. Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throu</description>
</item>
<item>
<title>Prenetics Authorizes $40 Million Share Repurchase Program</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-authorizes-dollar40-million-share-repurchase-program-31</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-authorizes-dollar40-million-share-repurchase-program-31</guid>
<pubDate>Fri, 06 Mar 2026 05:00:00 GMT</pubDate>
<description>Management and Board Have Collectively Committed Up to $42.75 Million to Prenetics Stock Backed by $164 Million in Total Adjusted Liquidity, Zero Debt IM8</description>
</item>
<item>
<title>Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-executives-execute-second-consecutive-round-of-post-earnings-open-market-share-purchases-of-dollar13-million-cumulative-personal-investment-across-both-rounds-reaches-dollar27-million</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-executives-execute-second-consecutive-round-of-post-earnings-open-market-share-purchases-of-dollar13-million-cumulative-personal-investment-across-both-rounds-reaches-dollar27-million</guid>
<pubDate>Tue, 03 Mar 2026 13:00:00 GMT</pubDate>
<description>- CEO Danny Yeung makes personal investment in this round of approximately $750,000, up from investment of approximately $502,000 in November 2025 NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that members of its executive leadership team have executed a second round of open market purchases of Prenetics common</description>
</item>
<item>
<title>Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-launches-im8-daily-ultimate-essentials-pro-a-clinical-formula-with-two-new-flavours</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-launches-im8-daily-ultimate-essentials-pro-a-clinical-formula-with-two-new-flavours</guid>
<pubDate>Mon, 23 Feb 2026 05:00:00 GMT</pubDate>
<description>Up to 733% Greater Potency Across 11 Key Nutrients, Including New Saffron Nootropic and Bioactive Vitamin Forms Two New Flavours — Mango + Passionfruit and</description>
</item>
<item>
<title>Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-completes-dollar70-million-insighta-sale-to-tencent-bolstering-balance-sheet-to-dollar1711-million-in-total-adjusted-liquidity</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-completes-dollar70-million-insighta-sale-to-tencent-bolstering-balance-sheet-to-dollar1711-million-in-total-adjusted-liquidity</guid>
<pubDate>Wed, 18 Feb 2026 14:25:00 GMT</pubDate>
<description>Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced on February 18, 2026 NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the completion of the sale of its 35% equity interest in Insighta to Tencent fo</description>
</item>
<item>
<title>Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-reports-record-q4-and-fy-2025-results-im8-achieves-dollar120m-arr-in-12-months-revenue-surges-480percent-yoy</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-reports-record-q4-and-fy-2025-results-im8-achieves-dollar120m-arr-in-12-months-revenue-surges-480percent-yoy</guid>
<pubDate>Wed, 18 Feb 2026 14:11:00 GMT</pubDate>
<description>Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenet</description>
</item>
<item>
<title>Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-appoints-renowned-longevity-expert-213000424</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-appoints-renowned-longevity-expert-213000424</guid>
<pubDate>Tue, 17 Feb 2026 21:30:00 GMT</pubDate>
<description>Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the appointment of Dr. Darshan Shah as an independent director to its Board of Directors (the “Board”), effective February 16, 2026.</description>
</item>
<item>
<title>Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/formula-1-phenom-ollie-bearman-130000138</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/formula-1-phenom-ollie-bearman-130000138</guid>
<pubDate>Fri, 13 Feb 2026 13:00:00 GMT</pubDate>
<description>Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand’s mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman’s rapid rise – including a historic points</description>
</item>
<item>
<title>Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-report-q4-full-2025-130000699</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-report-q4-full-2025-130000699</guid>
<pubDate>Wed, 11 Feb 2026 13:00:00 GMT</pubDate>
<description>NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced it will release financial results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Wednesday, February 18, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial resu</description>
</item>
<item>
<title>Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-provides-voluntary-warrant-exchange-130000625</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-provides-voluntary-warrant-exchange-130000625</guid>
<pubDate>Mon, 05 Jan 2026 13:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced an update to its previously announced voluntary warrant exchange program. Updated Participation and Impact In connection with the Company’s prior financing round in October 2025, 2,722,642 Class A ordinary shares were issued, with one Class A warrant and one Class B war</description>
</item>
<item>
<title>Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-update-to-capital-allocation-strategy-ceases-bitcoin-purchases-to-focus-on-im8</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-update-to-capital-allocation-strategy-ceases-bitcoin-purchases-to-focus-on-im8</guid>
<pubDate>Tue, 30 Dec 2025 05:00:00 GMT</pubDate>
<description>Company’s Capital and Strategic Focus Now Exclusively Focused on IM8 IM8 FY 2026 Revenue Projected to Reach $180 - $200 Million CHARLOTTE, N.C., Dec. 30, 2025</description>
</item>
<item>
<title>Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-enters-into-warrant-exchange-agreements-with-warrant-holders-strengthening-capital-structure</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-enters-into-warrant-exchange-agreements-with-warrant-holders-strengthening-capital-structure</guid>
<pubDate>Tue, 23 Dec 2025 05:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company</description>
</item>
<item>
<title>Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-executives-announce-open-market-share-purchases-totaling-approx-dollar145-million</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-executives-announce-open-market-share-purchases-totaling-approx-dollar145-million</guid>
<pubDate>Mon, 24 Nov 2025 05:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a</description>
</item>
<item>
<title>Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-reports-record-third-quarter-2025-results-im8-on-track-for-dollar120m-arr-by-december-2025-fastest-supplement-brand-growth-in-industry-history</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-reports-record-third-quarter-2025-results-im8-on-track-for-dollar120m-arr-by-december-2025-fastest-supplement-brand-growth-in-industry-history</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>Total Revenue Surges 568% YoY to $23.6 million; IM8 Monthly Revenue Hits Record US$9 million in October; Bitcoin Treasury Reaches 387 BTC (~$40M); IM8</description>
</item>
<item>
<title>Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-third-quarter-2025-financial-results-release-date-and-inaugural-earnings-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-third-quarter-2025-financial-results-release-date-and-inaugural-earnings-conference-call</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company,</description>
</item>
<item>
<title>Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-closing-of-approx-dollar440-million-equity-offering-to-fuel-im8s-global-expansion-and-bitcoin-treasury-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-closing-of-approx-dollar440-million-equity-offering-to-fuel-im8s-global-expansion-and-bitcoin-treasury-strategy</guid>
<pubDate>Tue, 28 Oct 2025 04:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company,</description>
</item>
<item>
<title>Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy</title>
<link>https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-oversubscribed-approximately-dollar48-million-equity-offering-with-potential-for-dollar216-million-in-total-proceeds-to-fuel-im8s-global-expansion-and-bitcoin-treasury-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/prenetics-global-ltd/news/prenetics-announces-oversubscribed-approximately-dollar48-million-equity-offering-with-potential-for-dollar216-million-in-total-proceeds-to-fuel-im8s-global-expansion-and-bitcoin-treasury-strategy</guid>
<pubDate>Mon, 27 Oct 2025 04:00:00 GMT</pubDate>
<description>Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading</description>
</item>
</channel>
</rss>